Therefore, the authors concluded that NRF2 plays an essential function in the regulation of breast cancer malignancy by influencing the Notch1 signaling pathway through the upregulation of G6PD, a rate-limiting enzyme of the PPP. Here, G6PD is linked to breast cancer.